FDA Inspection 1119867 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 2076545

The FDA completed an inspection of American Red Cross Blood Services on February 24, 2020 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santa Ana, CA (United States)